Researchers from New York Eye and Ear Infirmary of Mount Sinai, New York, reported that subretinal drusenoid deposits (SDDs) ...

SriniVas R. Sadda, MD, FARVO, recalls a residency case that highlights the transformative impact of OCT and OCT angiography.

Stephen Tsang, MD, PhD, professor at Columbia University and attending physician at NewYork-Presbyterian Hospital, shared encouraging early findings on the use of optogenetic therapy for patients with ...

Despite the recent attention to the potential of developing and using gene therapy to treat several diseases, the therapy was ...

The Eye Care Network sat down with Rajesh K. Rajpal, MD, ophthalmologist and founder of See Clearly Vision Group in McLean, ...

Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for ...

Dompé was selected by the US Food and Drug Administration (FDA) to participate in the Commissioner’s National Priority ...

Aurion Biotech has released positive 12-month results from its phase 1/2 CLARA trial evaluating the safety, efficacy, and ...

The dexamethasone insert effectively treats postoperative inflammation and allergic conjunctivitis, with a favorable safety ...

Bedrood describes improved visualization of the ciliary body, efficient setup, and favorable postoperative outcomes.

Stoke Therapeutics announced 2-year data from the FALCON study, a prospective natural history study in people with autosomal ...

Ophthalmologists from across the United States and around the globe gathered in Orlando, Florida over the October 17 through ...